Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TIGIT Antikörper

Der Kaninchen Chimeric Anti-TIGIT-Antikörper wurde für ELISA, FACS und BP validiert. Er ist geeignet, TIGIT in Proben von Maus zu detektieren.
Produktnummer ABIN7072547

Kurzübersicht für Rekombinanter TIGIT Antikörper (ABIN7072547)

Target

Alle TIGIT Antikörper anzeigen
TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 64
  • 16
  • 3
Maus

Wirt

  • 46
  • 31
  • 1
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 54
  • 25
  • 2
Chimeric

Konjugat

  • 49
  • 9
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser TIGIT Antikörper ist unkonjugiert

Applikation

  • 46
  • 33
  • 29
  • 25
  • 20
  • 20
  • 14
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Flow Cytometry (FACS), Blocking Peptide (BP)

Klon

1B4
  • Verwendungszweck

    Anti-TIGIT [1B4], Rabbit IgG, lambda

    Spezifität

    This antibody is specific for murine TIGIT.

    Produktmerkmale

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Aufreinigung

    Protein A affinity purified

    Immunogen

    This antibody was raised by immunising TIGIT-/- mice with recombinant murine TIGIT tetramers.

    Isotyp

    IgG lambda
  • Applikationshinweise

    The binding specificity of this antibody for TIGIT has been confirmed in ELISA analysis and by flow cytometry using P815 cells transfected with mouse TIGIT and activated mouse splenocytes (Dixon et al, 2018). This antibody also specifically stains activated primary wild-type T cells (Dixon et al, 2018). This antibody fully blocks CD155 binding to TIGIT, and acts as a TIGIT blocking antibody in vivo. Administration of this antibody increases experimental autoimmune encephalomyelitis (EAE) severity, and retards the growth of established MC38 colon carcinoma and GL261 glioblastoma (Dixon et al, 2018). This antibody synergises with anti-PD-1 blocking antibodies to achieve complete tumour regression in colon carcinoma models (Dixon et al, 2018). The original mouse IgG1 antibody does not deplete TIGIT-expressing CD4+ or CD8+ T cells in vivo, nor affect T cell proliferation in vitro (Dixon et al, 2018).

    Kommentare

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

    Andere Bezeichnung

    TIGIT

    Hintergrund

    VSTM3, T cell Ig and ITIM domain, T cell immunoreceptor with Ig and ITIM domains, V-set and transmembrane domain-containing protein 3, WUCAM

    UniProt

    P86176

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!